Apogee Therapeutics (NASDAQ:APGE) just reported results for the second quarter of 2024.
- Apogee Therapeutics reported earnings per share of -60 cents. This met the analyst estimate for EPS of -60 cents.
- The company did not report any revenue for the quarter.